Materias dentro de su búsqueda.
Mostrando 541 - 560 Resultados de 1,163 Para Buscar 'The Agency', tiempo de consulta: 0.04s Limitar resultados
  1. 541
    Pharmacoeconomic review report : Tenofovir alafenamide (Vemlidy) (Gilead Sciences Canada, Inc.)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  2. 542
    Pharmacoeconomic review report : Tapentadol hydrochloride extended-release tablet (Nucynta extended-release) (Paladin Labs Inc.)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  3. 543
    Pharmacoeconomic review report : Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi) (Gilead Sciences Canada, Inc.)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  4. 544
    Pharmacoeconomic review report : Sapropterin dihydrochloride (Kuvan)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  5. 545
    Pharmacoeconomic review report : Risankizumab (Skyrizi) (AbbVie)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  6. 546
    Pharmacoeconomic review report : Riociguat (Adempas)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  7. 547
    Pharmacoeconomic review report : Propiverine hydrochloride (Mictoryl/Mictoryl pediatric)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  8. 548
    Pharmacoeconomic review report : Nusinersen (Spinraza) (Biogen Canada Inc.)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  9. 549
    Pharmacoeconomic review report : Nitisinone (MDK-Nitisinone) (MendeliKABS inc.)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  10. 550
    Pharmacoeconomic review report : Mifepristone and misoprostol (Mifegymiso)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  11. 551
    Pharmacoeconomic review report : Lixisenatide (Adlyxine) (Sanofi-aventis Canada Inc.)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  12. 552
    Pharmacoeconomic review report : Ivabradine hydrochloride (Lancora)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  13. 553
    Pharmacoeconomic review report Emtricitabine/tenofovir alafenamide (Descovy)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  14. 554
    Pharmacoeconomic review report Empagliflozin and Metformin fixed-dose combination (Synjardy)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  15. 555
    Pharmacoeconomic review report Efinaconazole (Jublia) (Valeant Canada LP)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  16. 556
    Pharmacoeconomic review report Edoxaban (Lixiana)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  17. 557
    Pharmacoeconomic review report Dolutegravir (Tivicay)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  18. 558
    Pharmacoeconomic review report Dapagliflozin (Forxiga)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  19. 559
    Pharmacoeconomic review report Daclizumab (Zinbryta)
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico
  20. 560
    Pharmacoeconomic review report Cysteamine delayed-release capsules (Procysbi), Horizon Pharma Ireland Ltd
    “…Canadian Agency for Drugs and Technologies in Health…”
    Libro electrónico

Herramientas de búsqueda: